Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Spjald Fysioterapi ApS v. Autoriseret Fysioterapeut Betina Hansen Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.6% 0.6%   Bankruptcy risk   2.7% 3.4% 3.4% 3.4% 2.7% 5.7% 6.7% 6.7%   Credit score (0-100)   62 55 54 53 59 39 36 36   Credit rating   BBB BBB BBB BBB BBB BBB BBB BBB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   909 1,185 1,221 1,333 1,164 1,711 0.0 0.0   EBITDA   506 405 406 400 461 220 0.0 0.0   EBIT   200 116 106 94.3 158 -46.7 0.0 0.0   Pre-tax profit (PTP)   80.6 29.3 33.4 35.0 110.2 -91.8 0.0 0.0   Net earnings   60.0 22.6 25.1 27.4 84.7 -71.6 0.0 0.0   Pre-tax profit without non-rec. items   80.6 29.3 33.4 35.0 110 -91.8 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Tangible assets total   176 165 208 145 84.7 60.2 0.0 0.0   Shareholders equity total   110 133 158 149 234 162 112 112   Interest-bearing liabilities   2,189 1,912 1,855 1,510 1,092 769 837 837   Balance sheet total (assets)   2,408 2,167 2,215 1,812 1,548 1,242 950 950   Net Debt   2,187 1,894 1,855 1,365 1,024 762 837 837     See the entire balance sheet 1000.0 Volume  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   909 1,185 1,221 1,333 1,164 1,711 0.0 0.0   Gross profit growth   0.0% 30.3% 3.1% 9.1% -12.6% 47.0% -100.0% 0.0%   Employees   0 0 2 2 2 3 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 50.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,408 2,167 2,215 1,812 1,548 1,242 950 950   Balance sheet change%   0.0% -10.0% 2.2% -18.2% -14.5% -19.8% -23.5% 0.0%   Added value   506.2 404.8 405.8 400.0 464.1 220.3 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   2,032 -543 -498 -611 -606 -534 -60 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 3.0 4.0 5.0 -1.0 0.0 0.0   1000.0 Profitability  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   22.0% 9.8% 8.7% 7.1% 13.6% -2.7% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   8.3% 5.1% 4.9% 4.7% 9.4% -3.3% 0.0% 0.0%   ROI %   8.6% 5.3% 5.2% 5.1% 10.2% -3.9% 0.0% 0.0%   ROE %   54.6% 18.6% 17.3% 17.8% 44.2% -36.1% 0.0% 0.0%   1000.0 Solidity  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Equity ratio %   4.6% 6.1% 7.1% 8.2% 15.1% 13.1% 11.8% 11.8%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   432.1% 467.9% 457.1% 341.3% 222.0% 345.8% 0.0% 0.0%   Gearing %   1,988.7% 1,442.0% 1,176.2% 1,010.9% 466.5% 473.7% 744.7% 744.7%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   10.9% 4.2% 4.0% 3.5% 3.7% 4.8% 0.0% 0.0%   1000.0 Liquidity  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Quick Ratio   0.0 0.2 0.6 0.6 0.4 0.4 0.0 0.0   Current Ratio   0.0 0.2 0.6 0.6 0.4 0.4 0.0 0.0   Cash and cash equivalent   1.1 18.1 0.0 144.3 68.0 7.8 0.0 0.0   1000.0 Capital use efficiency  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -979.2 -262.6 -231.1 -138.1 -318.2 -370.5 -418.7 -418.7   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 203 200 232 73 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 203 200 231 73 0 0   EBIT / employee   0 0 53 47 79 -16 0 0   Net earnings / employee   0 0 13 14 42 -24 0 0